REFERENCES
- European Medicines Agency. ( 2009 ). Reflection Paper on the Extrapolation of Results From Clinical Studies Conducted Outside Europe to the EU Population. EMEA. Available at: www.emea.europa.eu/pdfs/human/ewp/69270208en.pdf (accessed May 25, 2012) .
- Glickman , S. W. , McHutchison , J. G. , Peterson , E. D. , Cairns , C. B. , Harrington , R. A. , Califf , R. M. , Schulman , K. A. ( 2009 ). Ethical and scientific implications of the globalization of clinical research . New England Journal of Medicine 360 : 816 – 823 .
- Quan , H. , Zhao , PL. , Zhang , J. , Roessner , M. , Aizawa , K. ( 2010 ). Sample size considerations for Japanese patients in a multi-regional trial based on MHLW guidance . Pharmaceutical Statistics 9 : 100 – 112 .
- International Conference on Harmonisation. (2006). International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Q&A for the ICH E5 guideline on ethnic factors in the acceptability of foreign data. Available at: www.ich.org/fileadmin/Public_Web_Site/ICH_Products/ Guidelines/Efficacy/E5_R1/Q_As/E5_Q_As_R5.pdf
- Ko , F. S. , Tsou , H. H. , Liu , J. P. , Hsiao , C. F. (2010). Sample size determination for a specific region in a multiregional trial. Journal of Biopharmaceutical Statistics 20:870–885.
- Ministry of Health , Labor , and Welfare of Japan. ( 2007 ). Basic Principles on Global Clinical Trials. Tokyo: MHLW .
- Naito , C. ( 2000 ). Necessity and requirements of bridging studies and their present status in Japan . International Journal of Clinical Pharmacology and Therapeutics 38 : 80 – 86 .
- Kawai , N. , Chuang-Stein , C. , Komiyama , O. , Il , Y. ( 2008 ). An approach to rationalize partitioning sample size into individual regions in a multiregional trial . Drug Information Journal 42 : 139 – 147 .
- Shih , W. J. ( 2001 ). Clinical trials for drug registrations in Asian-Pacific countries: Proposal for a new paradigm from a statistical perspective . Controlled Clinical Trials 22 : 357 – 366 .